Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1990 Jun;341(6):547-51.
doi: 10.1007/BF00171735.

The effect of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse

Affiliations
Comparative Study

The effect of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse

B Costall et al. Naunyn Schmiedebergs Arch Pharmacol. 1990 Jun.

Abstract

Ketotifen was compared to diazepam to inhibit aversive responding of the mouse in a black and white test box and in the rat social interaction test. Both drugs reduced aversive responding in the mouse to the brightly illuminated area of the test box and facilitated social interaction in the rat; ketotifen was approximately 100 times more potent than diazepam. The chronic administration of diazepam, ethanol, nicotine and cocaine in the mouse also reduced aversive responding but their withdrawal was associated with an increased behavioural suppression. The administration of ketotifen during the period of withdrawal from diazepam, ethanol, nicotine and cocaine prevented the exacerbation in aversive responding. It is concluded that ketotifen, like diazepam and 5-HT3 receptor antagonists, can reduce behavioural suppression in rodent models of anxiety and attenuate the behavioural consequences of withdrawal from treatment with drugs of abuse.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Pharmacol. 1986 Nov 12;131(1):95-8 - PubMed
    1. Neuropharmacology. 1987 Jul;26(7A):693-700 - PubMed
    1. Neuropharmacology. 1988 Nov;27(11):1097-101 - PubMed
    1. Eur J Pharmacol. 1983 Jan 21;86(3-4):321-8 - PubMed
    1. J Clin Invest. 1985 Sep;76(3):1096-101 - PubMed

Publication types